Open Access. Powered by Scholars. Published by Universities.®
Antitrust and Trade Regulation Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Institution
- Publication
- Publication Type
Articles 1 - 8 of 8
Full-Text Articles in Antitrust and Trade Regulation
Antitrust Law, Ronald J. Shingler
Antitrust Law, Ronald J. Shingler
Golden Gate University Law Review
No abstract provided.
Antitrust Law, Jeffrey L. Henze
Antitrust Law, Jeffrey L. Henze
Golden Gate University Law Review
No abstract provided.
Antitrust Law, Bartholomew Lee, Marlis Mcallister
Antitrust Law, Bartholomew Lee, Marlis Mcallister
Golden Gate University Law Review
No abstract provided.
Antitrust Law, Phyllis Mariam Cantor
Antitrust Law, Phyllis Mariam Cantor
Golden Gate University Law Review
No abstract provided.
Antitrust Law, Kevin Mcconnell
Antitrust Law, Kevin Mcconnell
Golden Gate University Law Review
No abstract provided.
Extraterritorial Application Of The Antitrust Laws And Retaliatory Legislation By Foreign Countries, Donald J. Curotto
Extraterritorial Application Of The Antitrust Laws And Retaliatory Legislation By Foreign Countries, Donald J. Curotto
Golden Gate University Law Review
This Comment will review the United States approach to subject matter jurisdiction determinations in foreign antitrust suits, articulate the provisions of the retaliatory legislation, and finally, evaluate the impact of such legislation on United States antitrust enforcement.
Pharmaceutical Reverse Payment Settlements: Presumptions, Procedural Burdens, And Covenants Not To Sue Generic Drug Manufacturers, Catherine J. K. Sandoval
Pharmaceutical Reverse Payment Settlements: Presumptions, Procedural Burdens, And Covenants Not To Sue Generic Drug Manufacturers, Catherine J. K. Sandoval
Faculty Publications
This Article analyzes recent developments in antitrust law, focusing on agreements between pharmaceutical patent holders and generic drug manufacturers that require a generic manufacturer to delay its market entry in exchange for a payment or other consideration from the patent holder. A predictable consequence of settlements that delay the marketing of a generic drug is that prices for the patented drug will remain higher than if the generic competitor had prevailed in its challenge to the patent's validity or the patent holder had failed to show that the generic infringed on its patent. Analysis of the legality of these settlements …
Huddle Up: Surveying The Playing Field On The Single Entity Status Of The National Football League In Anticipation Of American Needle V. Nfl, Constantine J. Avgiris
Huddle Up: Surveying The Playing Field On The Single Entity Status Of The National Football League In Anticipation Of American Needle V. Nfl, Constantine J. Avgiris
Jeffrey S. Moorad Sports Law Journal
No abstract provided.